S031-0537 Screening compound: 3-(benzylamino)-N-(4-methoxyphenyl)-1H-spiro[pyrido[2,3-b]pyrazine-2,3'-pyrrolidine]-1'-carboxamide

S031-0537 Screening compound: 3-(benzylamino)-N-(4-methoxyphenyl)-1H-spiro[pyrido[2,3-b]pyrazine-2,3'-pyrrolidine]-1'-carboxamide
S031-0537 Screening compound: 3-(benzylamino)-N-(4-methoxyphenyl)-1H-spiro[pyrido[2,3-b]pyrazine-2,3'-pyrrolidine]-1'-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S031-0537
3-(benzylamino)-N-(4-methoxyphenyl)-1H-spiro[pyrido[2,3-b]pyrazine-2,3'-pyrrolidine]-1'-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S031-0537

Molecular Formula

C25H26N6O2 (C25 H26 N6 O2)

Compound Name

3-(benzylamino)-N-(4-methoxyphenyl)-1H-spiro[pyrido[2,3-b]pyrazine-2,3'-pyrrolidine]-1'-carboxamide

IUPAC name

3-(benzylamino)-N-(4-methoxyphenyl)-1H-spiro[pyrido[23-b]pyrazine-23'-pyrrolidine]-1'-carboxamide

SMILES

COc(cc1)ccc1NC(N(CC1)CC11Nc(cccn2)c2N=C1NCc1ccccc1)=O

InChI

InChI=1S/C25H26N6O2/c1-33-20-11-9-19(10-12-20)28-24(32)31-15-13-25(17-31)23(27-16-18-6-3-2-4-7-18)29-22-21(30-25)8-5-14-26-22/h2-12,14,30H,13,15-17H2,1H3,(H,28,32)(H,26,27,29)/t25-/m0/s1

InChI Key

MYRIEQNYPLNNBB-VWLOTQADSA-N

MDL Number (MFCD)

MFCD27642797

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

442.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.241

Distribution Coefficient, logD

1.530

Water Solubility, LogSw

-3.41

Polar Surface Area

74.972

Acid Dissociation Constant (pKa)

13.61

Base Dissociation Constant (pKb)

9.10

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.00

S031-0537 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Spiro Library (21655 compounds)

TLR-8 ligands Library (674 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Female
  • Skin
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Targets:
  • Proteases
  • Others
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S031-0537 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S031-0537?
Check Price and Availability of S031-0537, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S031-0537 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S031-0537
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S031-0537
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S031-0537 available by request